{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:07:32Z","timestamp":1770412052094,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.clml.2013.10.011","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T23:26:54Z","timestamp":1384558014000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical Characteristics of 95 Patients With Ocular Adnexal and Uveal Lymphoma: Treatment Outcomes in Extranodal Marginal Zone Subtype"],"prefix":"10.1016","volume":"14","author":[{"given":"Craig A.","family":"Portell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Rybicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Macklis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Sweetenham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2013.10.011_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","article-title":"Occurrence and prognosis of extranodal lymphomas","volume":"29","author":"Freeman","year":"1972","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2013.10.011_bib2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.84.8.907","article-title":"Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival","volume":"84","author":"Jenkins","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clml.2013.10.011_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.eye.6700379","article-title":"Clinical features associated with survival of\u00a0patients with lymphoma of the ocular adnexa","volume":"17","author":"Jenkins","year":"2003","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clml.2013.10.011_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","article-title":"Lymphoma of the ocular adnexa: a study of\u00a0353 cases","volume":"31","author":"Ferry","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2013.10.011_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1755-3768.2011.02337.x","article-title":"Diffuse large B-cell lymphoma of\u00a0the\u00a0ocular adnexal region: a nation-based study","volume":"91","author":"Rasmussen","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clml.2013.10.011_bib6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/1097-0142(19940501)73:9<2395::AID-CNCR2820730924>3.0.CO;2-V","article-title":"Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma","volume":"73","author":"Bairey","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2013.10.011_bib7","doi-asserted-by":"crossref","unstructured":"Aronow MB, Portell CA, Sweetenham JW, et\u00a0al. Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes [e-pub ahead of print]. Ophthalmology. doi:10.1016\/j.ophtha.2013.09.004, accessed: October 18, 2013.","DOI":"10.1016\/j.ophtha.2013.09.004"},{"key":"10.1016\/j.clml.2013.10.011_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.2010.08429.x","article-title":"Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a\u00a0large cohort of patients","volume":"152","author":"Bayraktar","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2013.10.011_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-717X-4-60","article-title":"Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis","volume":"4","author":"De Cicco","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clml.2013.10.011_bib10","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ijrobp.2011.04.052","article-title":"Long-term outcomes and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy","volume":"82","author":"Hashimoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clml.2013.10.011_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/IOP.0b013e31821cc4bb","article-title":"Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival","volume":"26","author":"Rootman","year":"2011","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.clml.2013.10.011_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.81993","article-title":"Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients","volume":"59","author":"Lim","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.clml.2013.10.011_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2008.12.004","article-title":"Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma","volume":"90","author":"Tomita","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clml.2013.10.011_bib14","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.ophtha.2008.02.004","article-title":"Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases","volume":"115","author":"Demirci","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clml.2013.10.011_bib15","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in\u00a0extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2013.10.011_bib16","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1080\/10428190701457949","article-title":"Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma","volume":"48","author":"Lossos","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2013.10.011_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000074641","article-title":"Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma","volume":"65","author":"Raderer","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.clml.2013.10.011_bib18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/10428190310001641233","article-title":"Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab","volume":"45","author":"Morgensztern","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2013.10.011_bib19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0609.2004.00299.x","article-title":"Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva","volume":"73","author":"N\u00fcckel","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2013.10.011_bib20","first-page":"1578","article-title":"Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa","volume":"90","author":"Ferreri","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2013.10.011_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00277-006-0134-0","article-title":"Rituximab as first line treatment for MALT lymphoma of extraocular muscles","volume":"85","author":"Benetatos","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2013.10.011_bib22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bjo.2007.115626","article-title":"Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland","volume":"91","author":"Heinz","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clml.2013.10.011_bib23","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1080\/10428190802517781","article-title":"Uveal lymphoma: a variant of ocular adnexal lymphoma","volume":"49","author":"Fuller","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2013.10.011_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00417-004-1050-4","article-title":"Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report","volume":"243","author":"Coupland","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.clml.2013.10.011_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/path.1130","article-title":"Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases","volume":"197","author":"Coupland","year":"2002","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.clml.2013.10.011_bib26","series-title":"WHO Classification of Tumours of\u00a0Haematopoietic and Lymphoid Tissue","year":"2008"},{"key":"10.1016\/j.clml.2013.10.011_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.clml.2013.10.011_bib28","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.ophtha.2013.02.003","article-title":"Ocular adnexal lymphoma: assessment of a TNM staging system","volume":"120","author":"Aronow","year":"2013","journal-title":"Ophthalmology"},{"issue":"suppl","key":"10.1016\/j.clml.2013.10.011_bib29","volume":"30","author":"Williams","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2013.10.011_bib30","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1634\/theoncologist.2012-0425","article-title":"A\u00a0reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma","volume":"18","author":"Ponzoni","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2013.10.011_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bjo.85.1.63","article-title":"Long-term outcome of ocular adnexal lymphoma subtypes according to the REAL classification. Revised European and American lymphoma","volume":"85","author":"Auw-Haedrich","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clml.2013.10.011_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/01676830601169148","article-title":"Ocular adnexal lymphoma classified using the WHO classification: not only histology and stage, but also gender is a predictor of outcome","volume":"26","author":"Plaisier","year":"2007","journal-title":"Orbit"},{"key":"10.1016\/j.clml.2013.10.011_bib33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2013.10.011_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/ijc.23596","article-title":"Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: results of a single-center prospective case-control study","volume":"123","author":"Ferreri","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clml.2013.10.011_bib35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.pas.0000249445.28713.88","article-title":"Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci","volume":"31","author":"Ruiz","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2013.10.011_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hon.921","article-title":"Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples","volume":"28","author":"Carugi","year":"2010","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clml.2013.10.011_bib37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.1984","article-title":"Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions","volume":"209","author":"Chanudet","year":"2006","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.clml.2013.10.011_bib38","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3109\/10428194.2010.513751","article-title":"Ocular adnexal mucosa-associated lymphoid tissue lymphoma in Northern China: high frequency of numerical chromosomal changes and no evidence of an association with Chlamydia psittaci","volume":"51","author":"Zhang","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2013.10.011_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood-2005-06-2332","article-title":"Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci","volume":"107","author":"Rosado","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2013.10.011_bib40","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/cncr.22843","article-title":"Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics","volume":"110","author":"Husain","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2013.10.011_bib41","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","article-title":"Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial","volume":"30","author":"Ferreri","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2013.10.011_bib42","unstructured":"Aronow ME, Portell C, Sweetenham J, et\u00a0al. Uveal lymphoma: comparison of diagnostic imaging studies [abstract]. Presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology, May 5, 2013, Seattle, WA."}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265013004734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265013004734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:25:33Z","timestamp":1761870333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265013004734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S2152265013004734"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2013.10.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics of 95 Patients With Ocular Adnexal and Uveal Lymphoma: Treatment Outcomes in Extranodal Marginal Zone Subtype","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2013.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}